ABVC BioPharma Inc.

NASDAQ: ABVC · Real-Time Price · USD
2.87
-0.26 (-8.31%)
At close: Aug 19, 2025, 3:59 PM
2.91
1.39%
After-hours: Aug 19, 2025, 07:18 PM EDT

ABVC BioPharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
509.59K 152.43K 969.78K 355.8K
Cost of Revenue
763.00 302.04K 286.42K 5.09K
Gross Profit
508.83K -150K 683.37K 350.71K
Operating Income
-4.71M -6.77M -15.11M -11.71M
Interest Income
87.36K 185.48K 187.82K 43.2K
Pretax Income
-5.37M -8.03M -15.52M -11.21M
Net Income
-4.9M -7.79M -16.42M -12.84M
Selling & General & Admin
5.04M 5.55M 13.1M 11.05M
Research & Development
179.27K 1.06M 2.69M 1M
Other Expenses
-272 -211 1K n/a
Operating Expenses
5.21M 6.62M 15.8M 12.06M
Interest Expense
825.9K 1.31M 293.97K 227.21K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
5.21M 6.92M 16.08M 12.06M
Income Tax Expense
-111K 256.01K 797.78K 825.02K
Shares Outstanding (Basic)
11.67M 4.34M 3.17M 2.5M
Shares Outstanding (Diluted)
11.67M 4.34M 3.17M 2.5M
EPS (Basic)
-0.42 -1.8 -5.2 -5.1
EPS (Diluted)
-0.42 -1.8 -5.2 -5.1
EBITDA
-4.34M -6.33M -15.2M -10.97M
EBIT
-4.54M -6.71M -15.22M -10.98M
Depreciation & Amortization
200.92K 380.39K 23.8K 11.99K